Labadie; Sharada

Patent Applications and Registrations

Patent applications and USPTO patent grants for Labadie; Sharada.The latest application filed is for "tetrahydro- pyrido[3,4- b]indole estrogen receptor modulators and uses thereof".

Company Profile

4.10.14

Labadie; Sharada - Sunnyvale CA
Labadie; Sharada - South San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
TETRAHYDRO- PYRIDO[3,4- b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF App 20210236473 - Labadie; Sharada ; et al.	2021-08-05
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof Grant 10,966,963 - Labadie , et al. April 6, 2	2021-04-06
Heteroaryl estrogen receptor modulators and uses thereof Grant 10,654,867 - Labadie , et al.	2020-05-19
Heteroaryl Estrogen Receptor Modulators And Uses Thereof App 20200002353 - Labadie; Sharada ; et al.	2020-01-02
TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF App 20190152970 - LABADIE; Sharada ; et al.	2019-05-23
TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF App 20180235945 - LABADIE; SHARADA ; et al.	2018-08-23
Heterocyclic estrogen receptor modulators and uses thereof Grant 10,053,451 - Labadie , et al. August 21, 2	2018-08-21
Pyrazolo compounds and uses thereof Grant 10,035,801 - Albrecht , et al. July 31, 2	2018-07-31
Pyrrolidine amide compounds as histone demethylase inhibitors Grant 10,022,354 - Lai , et al. July 17, 2	2018-07-17
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof Grant 9,980,947 - Labadie , et al. May 29, 2	2018-05-29
Tetrahydroisoquinoline estrogen receptor modulators and uses thereof Grant 9,969,732 - Labadie , et al. May 15, 2	2018-05-15
Heteroaryl Estrogen Receptor Modulators And Uses Thereof App 20180002344 - Labadie; Sharada ; et al.	2018-01-04
TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF App 20170362228 - Labadie; Sharada ; et al.	2017-12-21
Tetrahydroisoquinoline Estrogen Receptor Modulators And Uses Thereof App 20170320871 - Labadie; Sharada ; et al.	2017-11-09
Pyrrolidine Amide Compounds As Histone Demethylase Inhibitors App 20170312252 - Lai; Kwong Wah ; et al.	2017-11-02
Heterocyclic Estrogen Receptor Modulators And Uses Thereof App 20160347742 - Labadie; Sharada ; et al.	2016-12-01
Estrogen Receptor Modulators And Uses Thereof App 20160175284 - Labadie; Sharada ; et al.	2016-06-23
TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF App 20160175289 - Labadie; Sharada ; et al.	2016-06-23
Pyrazolo Compounds And Uses Thereof App 20160060267 - Albrecht; Brian K. ; et al.	2016-03-03
Tricyclic heterocyclic compounds, compositions and methods of use thereof Grant 8,461,328 - Babu , et al. June 11, 2	2013-06-11
Tricyclic Heterocyclic Compounds, Compositions And Methods Of Use Thereof App 20110201593 - Babu; Srinivasan ; et al.	2011-08-18
Inflammation modulators Grant 7,176,314 - Cushing , et al. February 13, 2	2007-02-13
Inflammation modulators App 20030181472 - Clark, David L. ; et al.	2003-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.